NOA1 and hepatocellular carcinoma: In a nutshell, WTAP affected NOA1 to activate the GPX4 expression and reduce the Fe2+, improving GSH/GSSH levels to suppress ferroptosis of hepatoma cells, which may promote the occurrence and development of HCC.